Sustained release formulation of a peptide

Details Sustained release formulation of a peptide Sustained release formulation of a peptide

2006-09-19

2006-09-19

Pak, John (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S457000, C424S484000, C424S486000, C424S489000, C514S002600, C514S772300, C514S773000, C514S806000, C514S867000, C514S908000, C514S951000, C514S964000, C525S054100, C525S444000, C525S450000

Reexamination Certificate

active

07109166

ABSTRACT:
This invention is directed to a sustained release composition comprised of Compound (A) having the formulaor a pharmaceutically acceptable salt thereof, and a copolymer comprised of poly-(I)-lactic-glycolic-tartaric acid wherein the amino group of Compound (A) is ionically bound to a carboxyl group of the copolymer and wherein further the composition may be made into a sustained release pharmaceutical composition with pharmaceutically acceptable carrier(s).

REFERENCES:
patent: 5552520 (1996-09-01), Kim et al.
patent: 5672659 (1997-09-01), Shalaby et al.
patent: 2 133 252 (1999-07-01), None
patent: WO 94/15587 (1994-07-01), None
patent: 95/04752 (1995-02-01), None
patent: WO 97/39738 (1997-10-01), None
patent: WO 97/40085 (1997-10-01), None
patent: WO 00/09166 (2000-02-01), None
patent: WO 00/43435 (2000-07-01), None
patent: WO 01/12232 (2002-02-01), None

Affiliated with

Also associated with

Rating

Sustained release formulation of a peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release formulation of a peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release formulation of a peptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3567909